• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常人类卵巢上皮向卵巢癌转变不同阶段的标志物谱。

Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.

作者信息

van Niekerk C C, Boerman O C, Ramaekers F C, Poels L G

机构信息

Department of Cell Biology, University of Nijmegen, The Netherlands.

出版信息

Am J Pathol. 1991 Feb;138(2):455-63.

PMID:1992770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1886195/
Abstract

To investigate whether early changes in the transformation of normal ovarian epithelial cells into tumor cells can be detected with monoclonal antibodies, a comparative immunohistochemical study was performed on normal human ovarian mesothelial cells, cystomas, cystadenomas, ovarian carcinomas, as well as granulosa cell tumor. Using monoclonal antibodies against different keratin subtypes, it was shown that mesothelial cells, ovarian cysts, cystadenomas, and carcinomas all reacted positively with broad-spectrum anti-keratin monoclonal antibodies (MAbs), as well as with MAbs to keratins 7, 8, 18, and 19. Keratins 4 and 13 were not found in mesothelial cells, but positive groups of cells were identified in several cystomas, adenomas, and carcinomas. While mesothelial cells did not react with the pan-epithelial marker BW495/36, invaginating metaplastic mesothelial cells, inclusion cysts, cystomas, adenomas, and carcinomas showed an increasing reactivity with BW495/36, with an increasing degree of malignancy. The reactivity of MAbs against ovarian carcinoma-associated antigens (OV-TL 3, OC 125, MOv 18, and OV-TL 10) was limited to weak staining reaction in some mesothelial cells but were found to be positive on more than 50% of the ovarian cystadenomas and more than 90% of the ovarian carcinomas. Thecal and granulosa cells of primordial, primary, and secondary follicles all reacted positively with antibodies to the broad-spectrum keratins OV-TL 12/5 and RCK 102, and to keratins 8 and 18, but not with keratins 4, 7, 13, and 19. These keratins decreased or disappeared in granulosa cells of mature follicles (Graafian follicles), whereas granulosa cell tumors did not react with anti-keratin antibodies. The reactivity of BW 495/36 was negative or limited to traces in some granulosa cells. Ovarian carcinoma-associated antigens were not expressed in granulosa cells or granulosa cell tumors. The data indicate that mesothelial cells undergoing metaplastic changes finally resulting in ovarian cystadenomas (and carcinomas) initiate the synthesis of a 200-kd glycoprotein recognized by MAb (BW 495/36), the production of ovarian carcinoma associated antigens, in addition to focal production of keratin 4 and/or 13, as seen in several samples. The granulosa cell tumors decrease or switch off their keratin production and remain negative for the 200-kd glycoprotein and the ovarian carcinoma-associated antigens.

摘要

为了研究能否用单克隆抗体检测正常卵巢上皮细胞向肿瘤细胞转化的早期变化,我们对正常人卵巢间皮细胞、囊肿、囊腺瘤、卵巢癌以及颗粒细胞瘤进行了一项比较性免疫组织化学研究。使用针对不同角蛋白亚型的单克隆抗体,结果显示间皮细胞、卵巢囊肿、囊腺瘤和癌均与广谱抗角蛋白单克隆抗体(MAbs)以及针对角蛋白7、8、18和19的MAbs呈阳性反应。在间皮细胞中未发现角蛋白4和13,但在一些囊肿、腺瘤和癌中发现了阳性细胞群。虽然间皮细胞不与泛上皮标志物BW495/36反应,但内陷化生的间皮细胞、包涵囊肿、囊肿、腺瘤和癌与BW495/36的反应性随着恶性程度的增加而增强。针对卵巢癌相关抗原(OV-TL 3、OC 125、MOv 18和OV-TL 10)的MAbs的反应性在一些间皮细胞中仅限于弱染色反应,但在超过50%的卵巢囊腺瘤和超过90%的卵巢癌中呈阳性。原始卵泡、初级卵泡和次级卵泡的卵泡膜细胞和颗粒细胞均与针对广谱角蛋白OV-TL 12/5和RCK 102以及角蛋白8和18的抗体呈阳性反应,但不与角蛋白4、7、13和19反应。这些角蛋白在成熟卵泡(格拉夫卵泡)的颗粒细胞中减少或消失,而颗粒细胞瘤不与抗角蛋白抗体反应。BW 495/36在一些颗粒细胞中的反应性为阴性或仅限于微量。卵巢癌相关抗原在颗粒细胞或颗粒细胞瘤中不表达。数据表明,经历化生变化最终导致卵巢囊腺瘤(和癌)的间皮细胞开始合成一种被MAb(BW 495/36)识别的200-kd糖蛋白,产生卵巢癌相关抗原,此外,如在几个样本中所见,还局部产生角蛋白4和/或13。颗粒细胞瘤减少或停止其角蛋白产生,并且对200-kd糖蛋白和卵巢癌相关抗原保持阴性。

相似文献

1
Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.正常人类卵巢上皮向卵巢癌转变不同阶段的标志物谱。
Am J Pathol. 1991 Feb;138(2):455-63.
2
Changes in expression of differentiation markers between normal ovarian cells and derived tumors.正常卵巢细胞与衍生肿瘤之间分化标志物表达的变化。
Am J Pathol. 1993 Jan;142(1):157-77.
3
Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.卵巢肿瘤病理学的分化边缘:通过标记抗体监测上皮性卵巢肿瘤的首次发病情况。
Cancer Detect Prev. 1997;21(3):247-57.
4
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.单克隆抗体角蛋白7在腺癌鉴别诊断中的应用
Am J Pathol. 1990 Mar;136(3):641-55.
5
Monoclonal antibody against human ovarian tumor-associated antigens.抗人卵巢肿瘤相关抗原的单克隆抗体。
J Natl Cancer Inst. 1986 May;76(5):781-91.
6
Marker profile of mesothelial cells versus ovarian carcinoma cells.间皮细胞与卵巢癌细胞的标志物谱
Int J Cancer. 1989 Jun 15;43(6):1065-71. doi: 10.1002/ijc.2910430619.
7
Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.人组织激肽释放酶4(KLK4)在浆液性卵巢癌中高表达。
Clin Cancer Res. 2001 Aug;7(8):2363-71.
8
Immunocytochemical detection of ovarian carcinoma cells in serous effusions.浆液性积液中卵巢癌细胞的免疫细胞化学检测
Acta Cytol. 1993 May-Jun;37(3):272-9.
9
D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.D2-40不是浆液性积液中起源于间皮的细胞的特异性标志物。
Am J Surg Pathol. 2006 Jul;30(7):878-82. doi: 10.1097/01.pas.0000208280.29291.34.
10
Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.针对卵巢癌腹水细胞表面表达的人上皮分化抗原的小鼠单克隆抗体。
Cancer Res. 1987 Dec 15;47(24 Pt 1):6741-50.

引用本文的文献

1
External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity.肿瘤标志物分析的外部质量评估:最新进展及其对估计诊断敏感性和特异性的影响
Ger Med Sci. 2005 May 30;3:Doc02.
2
Linking the ovarian cancer transcriptome and immunome.连接卵巢癌转录组和免疫组。
BMC Syst Biol. 2008 Jan 3;2:2. doi: 10.1186/1752-0509-2-2.
3
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas.

本文引用的文献

1
Surface (germinal) epithelium and related ovarian neoplasms.表面(生发)上皮及相关卵巢肿瘤。
Pathol Annu. 1981;16 Pt 1:247-94.
2
Reactivity of a monoclonal antibody with human ovarian carcinoma.一种单克隆抗体与人卵巢癌的反应性。
J Clin Invest. 1981 Nov;68(5):1331-7. doi: 10.1172/jci110380.
3
Carcinoembryonic antigen localization in benign and malignant transitional epithelium.癌胚抗原在良性和恶性移行上皮中的定位
在正常人类卵巢表面上皮细胞和源自卵巢腺癌的细胞系之间,炎症相关基因表达存在改变。
Br J Cancer. 2005 May 23;92(10):1927-33. doi: 10.1038/sj.bjc.6602568.
4
Differential gene expression in ovarian carcinoma: identification of potential biomarkers.卵巢癌中的差异基因表达:潜在生物标志物的鉴定
Am J Pathol. 2004 Aug;165(2):397-414. doi: 10.1016/S0002-9440(10)63306-8.
5
Influence of tumor grade on expression of CA 125 in serum and tissue in patients with serous ovarian carcinoma.肿瘤分级对浆液性卵巢癌患者血清和组织中CA 125表达的影响。
Wien Klin Wochenschr. 2003 Apr 30;115(7-8):255-8. doi: 10.1007/BF03040324.
6
Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity.流式分选的卵巢肿瘤细胞的分子遗传学分析:提高杂合性缺失的检测率
Br J Cancer. 1994 Aug;70(2):255-62. doi: 10.1038/bjc.1994.289.
7
Demonstration of cytokeratin intermediate filaments in oocytes of the developing and adult human ovary.发育中和成年人类卵巢卵母细胞中细胞角蛋白中间丝的显示
Histochemistry. 1993 Apr;99(4):311-9. doi: 10.1007/BF00269104.
8
Changes in expression of differentiation markers between normal ovarian cells and derived tumors.正常卵巢细胞与衍生肿瘤之间分化标志物表达的变化。
Am J Pathol. 1993 Jan;142(1):157-77.
9
Presence of the intermediate filaments cytokeratins and vimentin in the rat corpus luteum during luteal life-span.在大鼠黄体生命周期中,中间丝细胞角蛋白和波形蛋白在黄体中的存在情况。
Histochem Cell Biol. 1995 Mar;103(3):237-42. doi: 10.1007/BF01454029.
Cancer. 1981 Mar 1;47(5):899-905. doi: 10.1002/1097-0142(19810301)47:5<899::aid-cncr2820470515>3.0.co;2-k.
4
Determinants of ovarian cancer risk. I. Reproductive experiences and family history.卵巢癌风险的决定因素。I. 生殖经历与家族史。
J Natl Cancer Inst. 1983 Oct;71(4):711-6.
5
Cytokeratins of normal epithelia and some neoplasms of the female genital tract.正常上皮组织及女性生殖道某些肿瘤的细胞角蛋白
Lab Invest. 1983 Nov;49(5):599-610.
6
Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.角蛋白丝单克隆抗体,对腺上皮及其肿瘤具有特异性。用于外科病理学。
Lab Invest. 1983 Sep;49(3):353-61.
7
Co-expression of cytokeratin and vimentin filaments in mesothelial, granulosa and rete ovarii cells of the human ovary.人卵巢间皮细胞、颗粒细胞和卵巢网细胞中细胞角蛋白丝和波形蛋白丝的共表达。
Eur J Cell Biol. 1985 May;37:175-90.
8
Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.人类卵巢及其肿瘤中的肿瘤标志物。一项比较性免疫组织化学研究。
Am J Pathol. 1987 Feb;126(2):230-42.
9
Monoclonal antibody against human ovarian tumor-associated antigens.抗人卵巢肿瘤相关抗原的单克隆抗体。
J Natl Cancer Inst. 1986 May;76(5):781-91.
10
Marker profile of mesothelial cells versus ovarian carcinoma cells.间皮细胞与卵巢癌细胞的标志物谱
Int J Cancer. 1989 Jun 15;43(6):1065-71. doi: 10.1002/ijc.2910430619.